Active	Status	Sponsor type	Region	Phase	Filter
2 Active 4 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Macías, Juan Antonio
NCT05297240: Retrospective Study of the Use of Belantamab Mafodotin (Blenrep®) in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) in Spain.	Recruiting	N/A	170	Europe	Belantamab mafodotin	PETHEMA Foundation, GlaxoSmithKline	RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA	12/22	12/22
Ibañez, Angela
NCT05297240: Retrospective Study of the Use of Belantamab Mafodotin (Blenrep®) in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) in Spain.	Recruiting	N/A	170	Europe	Belantamab mafodotin	PETHEMA Foundation, GlaxoSmithKline	RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA	12/22	12/22